Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Total Raised

$3M

Avirmax Funding, Avirmax Valuation & Avirmax Revenue

1 Fundings

Avirmax's latest funding round was a Unattributed for $3M on November 26, 2019.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

11/26/2019

Unattributed

$3M

Undisclosed Investors

$0.00B

((9.99x))

FY 1234

1

Date

11/26/2019

Round

Unattributed

Amount

$3M

Investors

Undisclosed Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.